ArticleJournal of Cancer2022

An insulin growth factor-I/II-neutralizing monoclonal antibody in combination with epidermal growth factor receptor inhibitors potently inhibits tumor cell growth.

Guofang Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.